
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (Oxford Biomedica or the Group), and Homology Medicines, Inc. (Nasdaq: FIXX) (Homology). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homologys innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Groups know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to...
Gene therapy and aav
Oxford biomedica solutions operates in the Pharmaceutical manufacturing industry.
Oxford biomedica solutions's revenue is 11m - 100m
Oxford biomedica solutions has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.